Resources & Documents
-
SBIR/STTR-Supported Drugs & Medical Devices Generate Over $60 billion in Annual Revenue
An economic analysis of drugs and medical devices reveals that the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs have played a pivotal role in supporting […]
-
SBIR/STTR Programs Have Lapsed
UPDATES: NSBA and SBTC have put out a joint press release urging Congress to act swiftly to pass HR 5100 and continue the SBIR/STTR programs. NSBA/SBTC Press Release on SBIR/STTR […]
-
House of Representatives Passes 1-Year SBIR/STTR Extension
UPDATE 9/15/25: The House of Representatives passed a 1-year extension of the SBIR/STTR programs under suspension of the rules. The bill will now go to the Senate, where it is […]
-
Chair Williams Introduces SBIR Reauthorization Bill
House Small Business Committee Chairman Roger Williams has introduced legislation to reauthorize the SBIR/STTR program, titled the INNOVATE Act. This bill largely mirrors the INNOVATE Act introduced by Senate Small […]
-
Congress Passes Permanent Sec. 174 R&D Tax Fix
The House of Representatives passed a permanent restoration of the Sec. 174 domestic R&D Tax deduction as part of its omnibus tax bill, also known as the “Big Beautiful Bill”. […]
Latest News
SBIR/STTR-Supported Drugs & Medical Devices Generate Over $60 billion in Annual Revenue
An economic analysis of drugs and medical devices reveals that the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs have played a pivotal role in supporting […]
Join SBTC Today
Support our efforts – become a member of SBTC! Click here to sign up online, or download our membership application today!
Testimonials
-
SBTC is the one organization I have been able to count on to represent the interests of my company on such important issues as reauthorization of the SBIR/STTR Programs, restoration of SBIR funding when agencies try to opt out, and small business patent protection. There are many battles yet to be fought and we need to join forces through SBTC to represent our interests.
Jim Woo, CEO Interscience Inc

